Information:
Fel:
ID
40084
Beskrivning
Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01602367
Länk
https://clinicaltrials.gov/show/NCT01602367
Nyckelord
Versioner (1)
- 2020-03-11 2020-03-11 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
11 mars 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hypertension NCT01602367
Eligibility Hypertension NCT01602367
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01602367
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Sitting diastolic blood pressure | Sitting systolic blood pressure
Item
qualifying seated blood pressure between ≥90 and ≤105 mmhg diastolic and ≤155 mmhg systolic
boolean
C1319894 (UMLS CUI [1])
C1319893 (UMLS CUI [2])
C1319893 (UMLS CUI [2])
Average 24 hour diastolic blood pressure
Item
mean 24-hour diastolic blood pressure ≥85 mmhg
boolean
C1282172 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) ≥27 kg/m2
boolean
C1305855 (UMLS CUI [1])
Oral hypoglycemic Dose Stable | Anticholesteremic Agents Dose Stable
Item
if receiving an oral anti-hyperglycemic medication or a cholesterol lowering medication, receiving a stable dose for at least 6 weeks
boolean
C0359086 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003277 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003277 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Cushing's disease | Cushing Syndrome | Addison Disease
Item
history of cushing's disease or syndrome, or addison's disease
boolean
C0221406 (UMLS CUI [1])
C0010481 (UMLS CUI [2])
C0001403 (UMLS CUI [3])
C0010481 (UMLS CUI [2])
C0001403 (UMLS CUI [3])
Hemoglobin A1c measurement
Item
glycosylated hemoglobin (hba1c) ≥10%
boolean
C0474680 (UMLS CUI [1])
Cerebrovascular accident | Angina, Unstable | Myocardial Infarction
Item
cerebrovascular insult, unstable angina, or myocardial infarction (mi) within 6 months
boolean
C0038454 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
Renal Insufficiency | Liver Dysfunction
Item
history of impaired renal or hepatic function
boolean
C1565489 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0086565 (UMLS CUI [2])
Body mass index
Item
bmi ≥50 kg/m2
boolean
C1305855 (UMLS CUI [1])
Hypoglycemic Agents Injectable | Insulin
Item
any injectable antihyperglycemic agent (such as insulin) within 16 weeks
boolean
C0020616 (UMLS CUI [1,1])
C0086466 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
C0086466 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2])
Antihypertensive Agents Class Quantity
Item
currently receiving more than one class of antihypertensive agents within 4 weeks
boolean
C0003364 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0456387 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Non-Steroidal Anti-Inflammatory Agents Daily
Item
daily use of nonsteroidal anti-inflammatory agents within 1 week
boolean
C0003211 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,2])
Androgens | Androgens for topical use
Item
use of androgen medications, including topical preparations, within 6 weeks
boolean
C0002844 (UMLS CUI [1])
C3653733 (UMLS CUI [2])
C3653733 (UMLS CUI [2])
Breast Carcinoma
Item
diagnosis or history of breast cancer
boolean
C0678222 (UMLS CUI [1])